MLB will investigate Curt Schilling’s claim that a Red Sox employee recommended he take PEDs

27 Comments

I spoke to a source with Major League Baseball this afternoon who tells me that MLB will investigate Curt Schilling’s claim on ESPN radio yesterday afternoon that a Boston Red Sox employee told him he should take PEDs when he was suffering from shoulder trouble in 2008.

The source did not say what, exactly, would be done, but it’s hard to see how any investigation of this claim does not begin with Schilling himself. Earlier today Schilling said he would not identify who told him to take PEDs in 2008. It will be interesting to see if he is any more forthcoming to the league.

Meanwhile, Sean McAdam of CSNNE.com spoke with a source who thinks Schilling is making a mountain out of a molehill:

… a source familiar with the situation said, “I’m sure if anyone said something like that, it wasn’t meant to be serious. I would bet my bottom dollar on that.”

Also this afternoon, Evan Drellich of MLB.com reported that team president/CEO Larry Lucchino said that the Boston Red Sox will look into the claim itself. As Schilling noted in his interview, however, the person is no longer employed by the Red Sox.

Baseball news has been dominated by drug stories for the past week and change. It looks like it will continue to be so dominated for a while longer.  But it is worth observing that Major League Baseball seems as serious about investigating an allegation relating to team personnel and PEDs as it is in investigating players who allegedly used. Which is a good thing.

RHP Fairbanks, Rays agree to 3-year, $12 million contract

tampa bay rays
Dave Nelson/USA TODAY Sports
0 Comments

ST. PETERSBURG, Fla. — Reliever Pete Fairbanks and the Tampa Bay Rays avoided arbitration when they agreed Friday to a three-year, $12 million contract that could be worth up to $24.6 million over four seasons.

The deal includes salaries of $3,666,666 this year and $3,666,667 in each of the next two seasons. The Rays have a $7 million option for 2026 with a $1 million buyout.

His 2024 and 2025 salaries could increase by $300,000 each based on games finished in the previous season: $150,000 each for 35 and 40.

Tampa Bay’s option price could increase by up to $6 million, including $4 million for appearances: $1 million each for 60 and 70 in 2025; $500,000 for 125 from 2023-25 and $1 million each for 135, 150 and 165 from 2023-25. The option price could increase by $2 million for games finished in 2025: $500,000 each for 25, 30, 35 and 40.

Fairbanks also has a $500,000 award bonus for winning the Hoffman/Rivera reliever of the year award and $200,000 for finishing second or third.

The 29-year-old right-hander is 11-10 with a 2.98 ERA and 15 saves in 111 appearances, with all but two of the outings coming out of the bullpen since being acquired by the Rays from the Texas Rangers in July 2019.

Fairbanks was 0-0 with a 1.13 ERA in 24 appearances last year after beginning the season on the 60-day injured list with a right lat strain.

Fairbanks made his 2022 debut on July 17 and tied for the team lead with eight saves despite being sidelined more than three months. In addition, he is 0-0 with a 3.60 ERA in 12 career postseason appearances, all with Tampa Bay.

He had asked for a raise from $714,400 to $1.9 million when proposed arbitration salaries were exchanged Jan. 13, and the Rays had offered for $1.5 million.

Fairbanks’ agreement was announced two days after left-hander Jeffrey Springs agreed to a $31 million, four-year contract with Tampa Bay that could be worth $65.75 million over five seasons.

Tampa Bay remains scheduled for hearings with right-handers Jason Adam and Ryan Thompson, left-hander Colin Poche, third baseman Yandy Diaz and outfielder Harold Ramirez.